Latest Research Reports

Report: Multiple pipeline products to drive growth of healthcare-associated infections market

Report: Multiple pipeline products to drive growth of healthcare-associated infections market

The US and the UK see a high percentage of CDT+ CDI cases

The US and the UK see a high percentage of CDT+ CDI cases

Report: Sepsis and septic shock treatment to be $5.9bn market by 2026

The market for sepsis and septic shock across the seven major pharmaceutical markets of the US, France, Germany, Italy, Spain, the UK, and Japan is expected to reach $5.9bn by 2026, according to...

Report: Sepsis and septic shock treatment to be $5.9bn market by 2026

Emerging rivals in CAR-T cell therapies

Emerging rivals in CAR-T cell therapies

Japan leads in preventing CDI recurrences

Japan leads in preventing CDI recurrences

The quest for efficient and cost-effective R&D remains a challenge

The quest for efficient and cost-effective R&D remains a challenge

AEDs targeting rare epilepsy syndromes set to shoot to top of the market

AEDs targeting rare epilepsy syndromes set to shoot to top of the market

Novartis leads Japanese clinical trials

Novartis leads Japanese clinical trials

Report: Global HER2-positive breast cancer market set to reach $9.89bn by 2025

The human epidermal growth factor receptor type 2 (HER2)-positive breast cancer market is expected to face competition from the launch of biosimilars, according to a report by...

Report: Global HER2-positive breast cancer market set to reach $9.89bn by 2025

Top sponsors for 2007-2016 stem cell therapy clinical trials

Top sponsors for 2007-2016 stem cell therapy clinical trials

Nanobodies leading the way for biotech R&D deal

Nanobodies leading the way for biotech R&D deal

Report: Clostridium difficile infections market to reach $1.7bn by 2026

The global clostridium difficile infections (CDIs) market is expected to witness a compound annual growth rate (CAGR) of 10.2%, increasing from $630m in 2016 to $1.7bn by 2026, according to...

Report: Clostridium difficile infections market to reach $1.7bn by 2026

Early detection of invasive breast cancer substandard in urban China

Early detection of invasive breast cancer substandard in urban China

Anti-diabetic treatments with non-glycemic benefits: driver of growth

Anti-diabetic treatments with non-glycemic benefits: driver of growth

Report: Canadian pharmaceuticals market to witness a nominal CAGR of 2% up to 2021

The Canadian pharmaceutical market is projected to witness a compound annual growth rate (CAGR) of 2%, growing from $22.6bn in 2016 to $25bn by 2021, according to a report by...

Report: Canadian pharmaceuticals market to witness a nominal CAGR of 2% up to 2021

US faces high, growing burden of CDI

US faces high, growing burden of CDI

Despite challenges, pain-related indications are most frequently researched clinical trials

Despite challenges, pain-related indications are most frequently researched clinical trials

Healthcare-related CDIs rivaled by community cases

Healthcare-related CDIs rivaled by community cases

Declining trend in Japanese clinical trials

Declining trend in Japanese clinical trials

Will Orencia be able to compete in an already crowded market?

Will Orencia be able to compete in an already crowded market?

Report: Heart failure market set to reach $16bn by 2026

The heart failure market is expected to witness a compound annual growth rate of 15.7%, from $3.7bn in 2016 to $16.1bn by 2026, according to a report by...

Report: Heart failure market set to reach $16bn by 2026